SCHEMBL976922

SCHEMBL976922

O=C(O)CN(Cc1ccccc1)C1=COCO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
PTPN1 P18031 1/20 0.39
HPGD P15428 1/20 0.36
NR3C1 P04150 1/20 0.36
TP53 P04637 1/20 0.36
LTA4H P09960 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HCAR3 P49019 1/20 0.35
KEAP1 Q14145 1/20 0.34
AKR1B1 P15121 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976808 0.83 ALDH1A1 (0.42) ALDH1A1TP53LTA4HKDM4ENPC1
SCHEMBL4747223 0.80 TRPM8 (0.42) ALDH1A1HPGDNPSR1NPC1RAB9A
SCHEMBL761128 0.74 TSHR (0.45) ALDH1A1HPGDCRHBPCRHR2NPC1
SCHEMBL7258846 0.73 CA2 (0.40) ALDH1A1HPGDNR3C1NPSR1MEN1
SCHEMBL1238800 0.73 OPRM1 (0.39) LTA4H
SCHEMBL2504679 0.73 AOC3 (0.41) ALDH1A1HPGDNPSR1NPC1RAB9A
SCHEMBL182883 0.73 CA2 (0.35) ALDH1A1HPGDNPSR1KDM4EMEN1
SCHEMBL3393849 0.72 OPRM1 (0.43) ALDH1A1HPGDNPC1RAB9A
SCHEMBL5717745 0.72 MEN1 (0.35) ALDH1A1HPGDNPSR1KDM4EMEN1
SCHEMBL5189401 0.72 TSHR (0.57) ALDH1A1PTPN1NR3C1NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440830-B2 Tetrahydro-fused pyridines as histone deacetylase inhibitors 4SC AG (DE) 2013-05-14 US disclosed
US-20110021494-A1 NOVEL TETRAHYDRO-FUSED PYRIDINES AS HISTONE DEACETYLASE INHIBITORS 4SC AG (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021494-A1 NOVEL TETRAHYDRO-FUSED PYRIDINES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HDAC3 ALDH1A1 912/4885PTPN1 3856/4885HPGD 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.